5 new weight-loss drugs to watch in the fight for the next Ozempic
Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.
Weight-loss drug Wegovy launched in China
Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.
The FDA’s risky action on compounding weight loss drugs
The FDA’s decision to allow the compounding of GLP-1 weight loss drugs could undermine its public health obligations, writes former FDA Commissioner @ScottGottliebMD.
Novo Nordisk Launches Wegovy Weight-Loss Drug in China
The first prescription for the drug in China will reportedly be issued at a public hospital in Shanghai this week and will cost about $193 for a one-month supply of the lowest dose.
Novo Nordisk launches obesity drug Wegovy in China
Novo Nordisk said on Monday it has launched its popular obesity drug Wegovy in China, the world's second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.
Popular weight-loss drug Wegovy goes on sale in China
Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June. It is set to intensify competition with rival Eli Lilly, whose popular weight-loss treatment also got the green light months ago but has yet to go on sale in the world's second largest pharmaceutical market.
Novo Nordisk sells hit weight-loss drug in China—at fraction of US price
Patients in China will be able to purchase the blockbuster weight-loss drug Wegovy for 1,400 yuan, or about $193, just a fraction of the US list price of $1,349, according to media reports. The price in China is in line with pricing elsewhere outside of the US.
Novo Nordisk's obesity drug Wegovy goes on sale in China
Novo Nordisk's blockbuster weight-loss drug Wegovy is now available for use in China, the company confirmed to AFP on Tuesday, as the Asian nation battles high rates of obesity.
Weight-Loss Drug Wegovy comes to China Amid Rising Demand
Novo Nordisk has officially launched its weight-loss drug Wegovy in China after receiving approval in June. The move pits it against rival Eli Lilly, whose treatment, Zepbound, is yet to hit shelves in the world's second-largest pharmaceutical market.
The 2-Week Cardio Challenge To Melt Belly Fat Quicker
A personal trainer outlines his ultimate two-week cardio workout to lose belly fat and lay a strong foundation for future ...
Daily2h
Novo Nordisk Enters China's Obesity Market with Wegovy Launch, Eyes 180 Million Patients
The move intensifies the competition with Eli Lilly, which secured approval for its weight loss drug in China in July but has ...
The Economist27d
Competition will make weight-loss drugs better, cheaper and bigger
At the same time, competition is likely to make weight-loss drugs both better and cheaper. Although Novo Nordisk and Eli Lilly are expected to dominate the market for the time being, challengers ...
rsvplive12d
Mum-of-two transforms her life and loses 3 stone in just 28 days with tailored fitness challenge
has successfully dropped over three stone by embracing a 28-day challenge. Simple's AI-driven platform offers users a ...
Opinion
The Poly Post8dOpinion
Culture of weight cutting needs to stop
By Alexis Alvarez, Nov.12, 2024 One hundred twenty-six pounds, the weight that haunted me throughout my four years of high school, and to this day, three years later, it's still in the back of my mind ...